Literature DB >> 171315

Epidemiology of cytomegalovirus infection after transplantation and immunosuppression.

M Fiala, J E Payne, T V Berne, T C Moore, W Henle, J Z Montgomerie, S N Chatterjee, L B Guze.   

Abstract

Viral infections and clinical complications were studied during hemodialysis and after renal transplantation. Active cytomegalovirus infection developed in 96% of patients after renal transplantation; reactivation of herpes simplex, varicella-zoster, and Epstein-Barr viruses was found in 35%, 24%, and 0% of patients, respectively. Cytomegalovirus viremia developed in 42% of patients an average of two months after renal transplantation, lasted 1.75 (+/- 1.5) months (except in one patient with chronic viremia), and was followed by chronic viruria. Higher titers of infectious cytomegalovirus were found in the polymorphonuclear than in the mononuclear leukocyte fraction. Reactivation of a latent infection and, less likely, respiratory infection appear to be the most probable mechanisms of cytomegalovirus infection after renal transplantation. One to three months after transplant, cytomegalovirus infection may be related to fever, arthralgia, pneumonitis, and leukopenia; three to four months after transplant, the virus may be related to hepatitis; and 12-30 months after transplant, it may be related to retinitis in patients with chronic viremia. Although other causes of these complications are possible, herpes simplex virus, Epstein-Barr virus, varicella-zoster virus, measles virus, adenovirus, hepatitis B virus, and Toxoplasma gondii appear to be of lesser importance than cytomegalovirus in this respect.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171315     DOI: 10.1093/infdis/132.4.421

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  80 in total

1.  Development of a quadriplex polymerase chain reaction for human cytomegalovirus detection.

Authors:  P Markoulatos; V Samara; N Siafakas; E Plakokefalos; N Spyrou; M L Moncany
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Cell-mediated immunity to cytomegalovirus in immunocompromised patients: effect of radiation or chemotherapy.

Authors:  Y Agatsuma; P Fitzpatrick; A Kaul; R Kaul; R Kohli; A V Paves; P L Ogra
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

Review 3.  Herpesviruses.

Authors:  M C Timbury; E Edmond
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

4.  Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus-specific IgM antibodies.

Authors:  G Henle; E T Lennette; M A Alspaugh; W Henle
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

5.  Clinical manifestations of infections with herpesviruses after kidney transplantation: a prospective study of various syndromes.

Authors:  S Naraqi; O Jonasson; G G Jackson; H M Yamashiroya
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969

6.  Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.

Authors:  Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2010-12-18       Impact factor: 5.258

7.  Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia.

Authors:  R L Saltzman; M R Quirk; M C Jordan
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

8.  Relationship between cytomegalovirus and colonization of the oropharynx by gram-negative bacilli following renal transplantation.

Authors:  P A Mackowiak; M Goggans; W Torres; A Dal Nogare; J P Luby; H Helderman
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

9.  Infectious mononucleosis and mononucleosis syndromes.

Authors:  M Fiala; D C Heiner; J A Turner; B Rosenbloom; L B Guze
Journal:  West J Med       Date:  1977-06

10.  Outcome of cytomegalovirus retinitis in immunocompromised patients without Human Immunodeficiency Virus treated with intravitreal ganciclovir injection.

Authors:  Aniruddha Agarwal; Neha Kumari; Amita Trehan; Alka Khadwal; Mangat R Dogra; Vishali Gupta; Aman Sharma; Amod Gupta; Ramandeep Singh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-21       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.